Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

8.56USD
19 Jul 2018
Change (% chg)

$-0.02 (-0.23%)
Prev Close
$8.58
Open
$8.69
Day's High
$8.75
Day's Low
$8.48
Volume
1,164
Avg. Vol
5,341
52-wk High
$15.75
52-wk Low
$5.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 2 3.65 5.00 2.30 --
Year Ending Apr-18 2 7.25 8.60 5.90 --
Year Ending Apr-19 2 11.70 14.40 9.00 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 2 -0.35 -0.26 -0.44 --
Year Ending Apr-18 2 -1.84 -1.74 -1.93 --
Year Ending Apr-19 2 -1.59 -1.58 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.70 24.26
Beta -- 0.90 0.89
Price to Sales (TTM) 151.44 3.94 5.73
Price to Book (MRQ) 2.63 4.88 5.47
Price to Tangible Book (MRQ) 2.63 5.70 7.05
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 80.82 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 2.28 8.01
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 7.87 2.94 3.03
LT Debt to Equity (MRQ) 0.80 10.03 12.51
Total Debt to Equity (MRQ) 1.55 14.07 16.84
Interest Coverage (TTM) -29.72 35.78 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.72 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 18.50 10.81
Operating Margin (TTM) -4,529.25 14.31 4.57
Operating Margin - 5 Yr. Avg. -- 14.45 6.23
Pre-Tax Margin (TTM) -4,120.21 14.80 5.43
Pre-Tax Margin - 5 Yr. Avg. -- 14.86 6.67
Net Profit Margin (TTM) -4,120.21 11.05 1.72
Net Profit Margin - 5 Yr. Avg. -- 11.16 2.94
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,055,695 860,399,112
Net Income/Employee (TTM) -- 112,126,539 101,210,045
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.01 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.58 11.14
Return on Assets - 5 Yr. Avg. -- 12.95 12.40
Return on Investment (TTM) -60.80 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.14
Return on Equity (TTM) -61.05 16.60 16.34
Return on Equity - 5 Yr. Avg. -- 17.97 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.22%
# of Holders: 32
Total Shares Held: 7,257,046
3 Mo. Net Change: 23,638
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.